Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 60 citing articles:

Mechanistic Insights into the Pharmacological Significance of Silymarin
Karan Wadhwa, Rakesh Pahwa, Manish Kumar, et al.
Molecules (2022) Vol. 27, Iss. 16, pp. 5327-5327
Open Access | Times Cited: 99
Role of silymarin as antioxidant in clinical management of chronic liver diseases: a narrative review
Alessio Aghemo, О. П. Алексеева, Francesco Angelico, et al.
Annals of Medicine (2022) Vol. 54, Iss. 1, pp. 1548-1560
Open Access | Times Cited: 70
Targeting Metabolic Diseases: The Role of Nutraceuticals in Modulating Oxidative Stress and Inflammation
Aida Dama, Kleva Shpati, Patricia Daliu, et al.
Nutrients (2024) Vol. 16, Iss. 4, pp. 507-507
Open Access | Times Cited: 39
Evaluating Bioactive-Substance-Based Interventions for Adults with MASLD: Results from a Systematic Scoping Review
Deepa Handu, Kim S. Stote, Tami A. Piemonte
Nutrients (2025) Vol. 17, Iss. 3, pp. 453-453
Open Access | Times Cited: 2
Fundamental Concepts and Novel Aspects of Polycystic Ovarian Syndrome: Expert Consensus Resolutions
Antônio Aversa, Sandro La Vignera, Rocco Rago, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 122
Traditional Chinese Medicine in nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives
Xian-min Dai, Jiayi Feng, Yi Chen, et al.
Chinese Medicine (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 61
Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis
Kailin Yang, Junpeng Chen, Tianqing Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 55
Silybin and its congeners: from traditional medicine to molecular effects
Vladimı́r Křen, Kateřina Valentová
Natural Product Reports (2022) Vol. 39, Iss. 6, pp. 1264-1281
Closed Access | Times Cited: 46
The Role of Tumor Necrosis Factor-Alpha in the Pathogenesis and Treatment of Nonalcoholic Fatty Liver Disease
Ilias D. Vachliotis, Stergios A. Pοlyzos
Current Obesity Reports (2023) Vol. 12, Iss. 3, pp. 191-206
Open Access | Times Cited: 42
Oxidative Stress and MicroRNAs in Endothelial Cells under Metabolic Disorders
Morgan Minjares, Wendy Wu, Jie‐Mei Wang
Cells (2023) Vol. 12, Iss. 9, pp. 1341-1341
Open Access | Times Cited: 26
Effect of alpha-lipoic acid and Silybum marianum supplementation with a Mediterranean diet on metabolic dysfunction-associated steatosis
Ana Contreras, María del Rocío Francisco, Jose Luis Vargas Basurto, et al.
World Journal of Hepatology (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 1
Natural Polyphenols in Metabolic Syndrome: Protective Mechanisms and Clinical Applications
Shiyao Zhang, Mengyi Xu, Wenxiang Zhang, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 6110-6110
Open Access | Times Cited: 56
Silymarin is an ally against insulin resistance: A review
Karla MacDonald-Ramos, Layla Michán, Alejandra Martínez-Ibarra, et al.
Annals of Hepatology (2020) Vol. 23, pp. 100255-100255
Open Access | Times Cited: 55
Circulating tumor necrosis factor‐α levels in non‐alcoholic fatty liver disease: A systematic review and a meta‐analysis
Victoria Potoupni, Maria Georgiadou, Eftychia Chatzigriva, et al.
Journal of Gastroenterology and Hepatology (2021) Vol. 36, Iss. 11, pp. 3002-3014
Closed Access | Times Cited: 44
A Molecular Insight into the Role of Antioxidants in Nonalcoholic Fatty Liver Diseases
Devaraj Ezhilarasan, Lakshmi Thangavelu
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 36
Combination Therapies for Nonalcoholic Fatty Liver Disease
Evangelia Makri, Eleftheria Makri, Stergios A. Pοlyzos
Journal of Personalized Medicine (2022) Vol. 12, Iss. 7, pp. 1166-1166
Open Access | Times Cited: 36
Supplementation of Silymarin Alone or in Combination with Salvianolic Acids B and Puerarin Regulates Gut Microbiota and Its Metabolism to Improve High-Fat Diet-Induced NAFLD in Mice
Xin Wang, Yufeng Jin, Can Di, et al.
Nutrients (2024) Vol. 16, Iss. 8, pp. 1169-1169
Open Access | Times Cited: 8
A Prospective Randomised Comparative Four-arm Intervention Study of Efficacy and Safety of Saroglitazar and Vitamin E in Patients With Non-alcoholic Fatty Liver Disease (NAFLD)/Non-alcoholic Steatohepatitis (NASH)-SVIN TRIAL
Bilal Ahmad Mir, Brij Kishore Sharma, Rajesh Sharma, et al.
Journal of Clinical and Experimental Hepatology (2024) Vol. 14, Iss. 5, pp. 101398-101398
Closed Access | Times Cited: 7
Silibinin’s Effects against Methotrexate-Induced Hepatotoxicity in Adjuvant-Induced Arthritis Rat Model
Ghada Khawaja, Youmna El-Orfali
Pharmaceuticals (2024) Vol. 17, Iss. 4, pp. 431-431
Open Access | Times Cited: 7
Vitamin E for people with non-alcoholic fatty liver disease
Hong-Zhu Wen, Hongyong Deng, Lili Yang, et al.
Cochrane library (2024) Vol. 2024, Iss. 10
Closed Access | Times Cited: 7
Oxidative Stress as a Target for Non-Pharmacological Intervention in MAFLD: Could There Be a Role for EVOO?
Aurelio Seidita, Alessandra Cusimano, Alessandra Giuliano, et al.
Antioxidants (2024) Vol. 13, Iss. 6, pp. 731-731
Open Access | Times Cited: 6
Diagnostic and therapeutic strategies for non-alcoholic fatty liver disease
Yajie Fu, Yanzhi Zhou, Linhu Shen, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 27
A Comprehensive Review of the Cardiovascular Protective Properties of Silibinin/Silymarin: A New Kid on the Block
Nikolaos P.E. Kadoglou, Chrystalla Panayiotou, Michail Vardas, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 538-538
Open Access | Times Cited: 25
Silibinin Attenuates Experimental Periodontitis by Downregulation of Inflammation and Oxidative Stress
Xumin Li, Runqi Zhou, Yue Han, et al.
Oxidative Medicine and Cellular Longevity (2023) Vol. 2023, pp. 1-12
Open Access | Times Cited: 16
Silybin: A Review of Its Targeted and Novel Agents for Treating Liver Diseases Based on Pathogenesis
Jijiao Wu, Wen Lin, Xiaolian Liu, et al.
Phytotherapy Research (2024)
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top